Shen et al. found a correlation between high levels of EpCAM + CTCs and lower survival in patients with unresectable HCC tumors after TACE, in addition to a correlation between high pre-surgical levels and a greater likelihood of recurrence [134,135]. This evidence concerns the gene EPCAM and hepatocellular carcinoma.